NF
ABBV icon

NTB Financial’s AbbVie ABBV Stock Holding History

NTB Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$628K Hold
4,100
– – 0.51% 58
2022
Q1 		$665K Buy
4,100
+45
+1% +$6.54K 0.48% 59
2021
Q4 		$549K Buy
+4,055
New +$479K 0.38% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NTB Financial's ABBV Position: Q2 2022 in Review

NTB Financial held its AbbVie (ABBV) position steady in Q2 2022 at 4,100 shares worth $628K. The position accounts for 0.51% of the portfolio, ranked #58.

NTB Financial first reported a position in ABBV in Q4 2021 and has held it in 3 quarters since. The position peaked at $665K in Q1 2022. 3,006 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • NTB Financial held 4,100 shares of AbbVie worth $628K as of Q2 2022.
  • NTB Financial left its AbbVie share count unchanged in Q2 2022.
  • AbbVie made up 0.51% of NTB Financial's portfolio in Q2 2022, its #58 holding.
  • NTB Financial first reported a position in AbbVie in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's AbbVie position peaked at $665K in Q1 2022.
  • 3,006 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.